GeoVax to Participate in the Alliance Global Partners’ Virtual Healthcare Symposium

NEXT STORY
Retinal Biologics Market worth USD 34,891.44 Million by 2027, at 11.5% CAGR | Market Research Future (MRFR)
PREV STORY
89bio Initiates Phase 2b ENLIVEN Trial of BIO89-100 for the Treatment of NASH
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

EyePoint Pharmaceuticals Reports Positive 30-day Safety Results for all Cohorts from the DAVIO Trial of EYP-1901 for wet-AMD

author_avatar
NASDAQ Market News

Enlivex Therapeutics Announces Positive Interim Safety and Efficacy Data From Ongoing Trial of Off-The-Shelf Allocetra in Patients with Severe Sepsis

author_avatar
NASDAQ Market News

Evaxion Biotech Announces Filing of Registration Statement in the U.S. for Proposed Initial Public Offering of Securities

author_avatar
NASDAQ Market News